STRIDES PHARMA SCIENCE has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Dec-17* | 3 Sep-18* | 3 Dec-18* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 7,490 | 7,326 | 7,945 | 8.4% | 6.1% |
Other income | Rs m | 157 | 77 | 8 | -89.3% | -94.7% |
Turnover | Rs m | 7,647 | 7,404 | 7,953 | 7.4% | 4.0% |
Expenses | Rs m | 6,262 | 6,330 | 6,674 | 5.4% | 6.6% |
Gross profit | Rs m | 1,166 | 922 | 1,278 | 38.6% | 9.7% |
Depreciation | Rs m | 391 | 445 | 407 | -8.6% | 4.1% |
Interest | Rs m | 498 | 485 | 501 | 3.3% | 0.6% |
Profit before tax | Rs m | 434 | 70 | 379 | 443.8% | -12.6% |
Tax | Rs m | -2 | 16 | 63 | 293.2% | |
Profit after tax | Rs m | 435 | 54 | 316 | 489.0% | -27.5% |
Gross profit margin | % | 15.6 | 12.6 | 16.1 | ||
Effective tax rate | % | -0.4 | 23.1 | 16.7 | ||
Net profit margin | % | 5.7 | 0.7 | 4.0 |
To see how STRIDES PHARMA SCIENCE has performed over the last eight quarters, please visit here.
Over the last one year, STRIDES PHARMA SCIENCE share price has moved up from Rs 785.6 to Rs 503.7, registering a Loss of Rs 281.9 or around 35.9%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,736.9 (down 0.2%). Over the last one year it has moved down from 14,799.8 to 13,736.9, a gain of 1,063 points (down 7.2%).
Overall, the S&P BSE SENSEX is down 1.9% over the year.
At the current price of Rs 503.7, the price to earnings (P/E) ratio of STRIDES PHARMA SCIENCE stands at 72.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.2 times.
For the quarter ended December 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 621 m (down 46.4% YoY). Sales on the other hand came in at Rs 8 bn (up 13.6% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.
For the quarter ended June 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 1 bn (up 184.5% YoY). Sales on the other hand came in at Rs 8 bn (up 14.0% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.
More Views on NewsIn this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.
Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
More
| |
Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!